Name: KIRAN LASOD Age/Gender: 55 Years/Female

0000009116159

Referred By: Client Name: Laxmi laboratory

Collection Date: 09-11-2024 14:29:00 Report Release Date: 10-11-2024 13:27:40

GD Marwar Health Package

No. Investigation Observed Value Unit Biological Ref. Interval

Complete Haemogram Test

Erythrocytes
1 Total Red Blood Cell Count (RBC) 4.2 10^6/µL 4.1-5.1
2 Hemoglobin 11.8 g/dL 12.3-15.3

3 Hematocrit (PCV) 36.3 % 33-57

4 Mean Corpuscular Volume (MCV) 86.1 fL 80-96
5 Mean Corpuscular Hemoglobin (MCH) 28.1 pg 27.5-33.2
6 Mean Corpuscular Hemoglobin Concentration 32.6 g/dL 29.4- 34.5
(MCHC)
7 Red Cell Distribution Width (RDW-CV) 15.2 % 12-15

8 Red Cell Distribution Width-SD(RDW-SD) 41.7 fl 32-60.4

9 Nucleated Red Blood Cells 0.0 cells/µL 0 - 1.36
10 Nucleated Red Blood Cells Percentage 0.0 % 0-4

Platelets
11 Platelet Count 245.0 10^3/µL 150-450
12 Mean Platelet Volume (MPV) 7.5 fL 6 - 12
13 Platelet Distribution Width (PDW) 17.0 % 15.5-18.3
14 Plateletcrit (PCT) 0.184 % 0.12-0.37

Leucocytes
15 Total Leucocytes Count 3.9 10^3/µL 4.4-11

16 Neutrophils 51.6 % 40-77

17 Lymphocyte Percentage 37.8 % 16-44
18 Monocytes Percentage 7.0 % 2.0-10.0
19 Eosinophils Percentage 3.4 % 0-7
20 Basophils Percentage 0.2 % 0-1
21 Neutrophils-Absolute Count 2.01 10^3/µL 1.8-7.8
22 Lymphocytes-Absolute Count 1.47 10^3/µL 1-4.8
23 Monocytes-Absolute Count 0.27 10^3/µL 0.1-1.0
24 Eosinophils-Absolute Count 0.13 10^3/µL 0 - 0.45

CRM No :9116159
Sample Recd. Time: 10-11-2024 10:26
Report Time: 10-11-2024 13:27 Authorized Signatory
Patient Name: KIRAN LASOD Dr. Murari lal Dhanetwal
Patient ID: 9116159 MBBS,MD (Pathology)
Scan For Report Scan To Verify
Consultant Pathologist.
Page 1 of 10
 Name: KIRAN LASOD Age/Gender: 55 Years/Female
0000009116159

Referred By: Client Name: Laxmi laboratory

Collection Date: 09-11-2024 14:29:00 Report Release Date: 10-11-2024 13:27:40

GD Marwar Health Package

No. Investigation Observed Value Unit Biological Ref. Interval

Leucocytes

25 Basophils-Absolute Count 0.01 10^3/µL 0-0.2

Peripheral Blood Smear

26 RBC Morphology Normocytic
Normochromic
27 WBC Morphology Within Normal
Range
28 Platelets Adequate On
Smear

Remarks

Kindly Correlate Clinically.

Interpretation

Sample type: EDTA whole blood.

Test Methods:

RBC/WBC/Platelets: Impedance method,

Hemoglobin: Photometric measurement,

Differential count: VCSn Technology,

MCV, MPV: Measured parameter Indices,

Absolute counts: Calculated.

(Processed on Fully Automated 5 parts differential Hematology analyzer).

CRM No :9116159
Sample Recd. Time: 10-11-2024 10:26
Report Time: 10-11-2024 13:27 Authorized Signatory
Patient Name: KIRAN LASOD Dr. Murari lal Dhanetwal
Patient ID: 9116159 MBBS,MD (Pathology)
Scan For Report Scan To Verify
Consultant Pathologist.
Page 2 of 10
 Name: KIRAN LASOD Age/Gender: 55 Years/Female
0000009116159

Referred By: Client Name: Laxmi laboratory

Collection Date: 09-11-2024 14:29:00 Report Release Date: 10-11-2024 13:27:40

GD Marwar Health Package

No. Investigation Observed Value Unit Biological Reference Interval

Liver Function Test

1 Bilirubin Total 0.6 mg/ dL 0.2-1.2

Serum, Method: Jendrassik Grof

2 Bilirubin Direct 0.11 mg/ dL 0.01 - 0.4

Serum, Method: Diazotization

3 Bilirubin Indirect 0.5 mg/dL 0.01-1.0

Serum, Method: Calculated

4 Aspartate Transaminase (AST/SGOT) 25.0 U/ L <35

Serum, Method: IFCC without P5P

5 Alanine Transaminase (ALT/SGPT) 19.0 U/ L <35

Serum, Method: IFCC without P5P

6 Alkaline Phosphatase 46.0 U/L 30 - 130

Serum, Method: AMP – pNPP Kinetic

7 Total Protein 7.4 g/dL 6.4 - 8.2

Serum, Method: Biuret end point

8 Albumin 3.9 g/dL 3.4 - 5

Serum, Method: Bromocresol Purple (BCP)

9 Globulin 3.5 g/dL 1.9-3.9

Serum, Method: Calculated

10 A/G ratio 1.11 Ratio 1.0 - 2.0

Serum, Method: Calculated

11 Gamma GT 23.0 U/L 5 - 55

Serum, Method: G glutamyl carboxy nitroanilide

CRM No :9116159
Sample Recd. Time: 10-11-2024 10:26
Report Time: 10-11-2024 13:27 Authorized Signatory
Patient Name: KIRAN LASOD Dr. Murari lal Dhanetwal
Patient ID: 9116159 MBBS,MD (Pathology)
Scan For Report Scan To Verify
Consultant Pathologist.
Page 3 of 10
 Name: KIRAN LASOD Age/Gender: 55 Years/Female
0000009116159

Referred By: Client Name: Laxmi laboratory

Collection Date: 09-11-2024 14:29:00 Report Release Date: 10-11-2024 13:27:40

GD Marwar Health Package

No. Investigation Observed Value Unit Biological Reference Interval

Lipid Profile

1 Total Cholesterol 237.0 mg/dL Desirable: <200

Serum, Method: Cholesterol Borderline high = 200-239
oxidase,esterase,peroxidase High: > 240
2 Triglycerides 123.0 mg/dL Desirable: <150
Serum, Method: Enzymatic, end point GPO-POD Borderline High: 150 - 199
High: > 200 - 499
3 HDL-Cholesterol 58.0 mg/dL 30 - 60
Serum, Method: Enzymatic Immunoinhibition

4 LDL- Cholesterol 154.40 mg/dL Optimal: <100;

Serum, Method: Calculated Near Optimal: 100-129;
Borderline High: 130-159;
High: 160-189;
Very high: >190
5 Cholesterol/HDL ratio 4.09 Optimal: <3.5
Serum, Method: Calculated Near Optimal: 3.5 - 5.0
High >5.0
6 VLDL Cholesterol 24.60 mg/dL 6 - 40
Serum, Method: Calculated

7 Non HDL Cholesterol 179.00 mg/dl Desirable: <130

Serum, Method: Calculated Borderline high: 130-159
High : 160-189
Very High :>190
8 LDL /HDL ratio 2.66 Optimal: <2.5
Serum, Method: Calculated Near Optimal: 2.5-3.5
High >3.5

Interpretation
1.Triglycerides: When triglycerides are very high greater than 1000 mg/dL, there is a risk of developing pancreatitis in children
and adults. Triglycerides change dramatically in response to meals, increasing as much as 5 to 10 times higher than fasting
levels just a few hours after eating. Even fasting levels vary considerably day to day. Therefore, modest changes in fasting
triglycerides measured on different days are not considered to be abnormal.
2. HDL-Cholesterol: HDL- C is considered to be beneficial, the so-called "good" cholesterol, because it removes excess
cholesterol from tissues and carries it to the liver for disposal. If HDL-C is less than 40 mg/dL for men and less than 50 mg/dL
for women, there is an increased risk of heart disease that is independent of other risk factors, including the LDL-C level. The
NCEP guidelines suggest that an HDL cholesterol value greater than 60 mg/dL is protective and should be treated as a negative
risk factor.
3. LDL-Cholesterol: Desired goals for LDL-C levels change based on individual risk factors. For young adults, less than 120
mg/dL is acceptable. Values between 120-159 mg/dL are considered Borderline high. Values greater than 160 mg/dL are
considered high. Low levels of LDL cholesterol may be seen in people with an inherited lipoprotein deficiency and in people
with hyperthyroidism, infection, inflammation, or cirrhosis.

CRM No :9116159
Sample Recd. Time: 10-11-2024 10:26
Report Time: 10-11-2024 13:27 Authorized Signatory
Patient Name: KIRAN LASOD Dr. Murari lal Dhanetwal
Patient ID: 9116159 MBBS,MD (Pathology)
Scan For Report Scan To Verify
Consultant Pathologist.
Page 4 of 10
 Name: KIRAN LASOD Age/Gender: 55 Years/Female
0000009116159

Referred By: Client Name: Laxmi laboratory

Collection Date: 09-11-2024 14:29:00 Report Release Date: 10-11-2024 13:27:40

GD Marwar Health Package

No. Investigation Observed Value Unit Biological Reference Interval

Thyroid Profile - Total T3,Total T4,TSH (TFT)

1 Total T3 114.28 ng/dL 40-181

Serum, Method: CLIA

2 Total T4 15.32 µg/dL 4.5 - 14.5

Serum, Method: CLIA

3 TSH (Thyroid Stimulating Hormone) 2.31 µIU/ml 0.35 - 5.5

Serum, Method: CLIA

Interpretation
1. Triodothyronine (T3) is produced by the thyroid gland and along with thyroxine (T4) help control the rate at which the body
uses energy.Elevated T3 denote hyperthyroidism while low levels indicate hypothyroidism.
2.The most common causes of thyroid dysfunction are related to autoimmune disorders. Graves disease causes hyperthyroidism,
but it can also be caused by thyroiditis, thyroid cancer, and excessive production of TSH. Total T3 is used to assess thyroid
function.
3. Elevated T4 levels may indicate hyperthyroidism. They may also indicate other thyroid problems, such as thyroiditis or toxic
multinodular goiter. Abnormally low levels of T4 may indicate: dietary issues, such as fasting, malnutrition, or an iodine
deficiency, medications that affect protein levels, hypothyroidism, illness.
4. Thyroid-stimulating hormone (TSH) stimulates the production and release of T4 (primarily) and T3. They help control the
rate at which the body uses energy and are regulated by a feedback system. Most of the T4 circulates in the blood bound to
protein, while a small percentage is free (not bound).
5. Lab has estimated Total T4 reference intervals that are specific for India, using the indirect sampling technique following
CLSI EP28-A3c document: Defining Establishing, and Verifying Reference Intervals in the Clinical Laboratory: Approved
Guideline-Third Edition.
5. Thyroid hormone status during pregnancy:

Pregnancy stage TSH (µIU/ml) T3 (ng/dl) T4 (µg/dL)

First trimester 0.05-3.70 71-175 6.5-10.1

Second trimester 0.31-4.35 91-195 7.5-10.3
Third trimester 0.41-5.18 104-182 6.3-9.7

CRM No :9116159
Sample Recd. Time: 10-11-2024 10:26
Report Time: 10-11-2024 13:27 Authorized Signatory
Patient Name: KIRAN LASOD Dr. Murari lal Dhanetwal
Patient ID: 9116159 MBBS,MD (Pathology)
Scan For Report Scan To Verify
Consultant Pathologist.
Page 5 of 10
 Name: KIRAN LASOD Age/Gender: 55 Years/Female
0000009116159

Referred By: Client Name: Laxmi laboratory

Collection Date: 09-11-2024 14:29:00 Report Release Date: 10-11-2024 13:27:40

GD Marwar Health Package

No. Investigation Observed Value Unit Biological Reference Interval

Kidney Function Test

1 Uric Acid 3.8 mg/ dL 2.0 - 6.5

Serum, Method: Uricase, UV

2 BUN (Blood Urea Nitrogen) 15.0 mg/dL 3.3 - 18.7

Serum, Method: Calculated

3 Urea 32.0 mg/dL 7 - 40

Serum, Method: Urease-GLDH

4 Creatinine 0.56 mg/dL 0.4 - 1.2

Serum, Method: Alkaline picrate kinetic

5 BUN/Creatinine ratio 26.79 5.0 - 23.5

Serum, Method: Calculated

6 Urea/Creatinine Ratio 57.14 10 - 50

Serum, Method: Calculated

Interpretation
A renal function panel could be ordered when a patient has risk factors for kidney dysfunction such as high blood pressure
(hypertension), diabetes, cardiovascular disease, obesity, elevated cholesterol, or a family history of kidney disease. A renal
function panel may also be ordered when someone has signs and symptoms of kidney disease, though early kidney disease often
does not cause any noticeable symptoms. It may be initially detected through routine blood or urine testing. Renal function panel
results are not diagnostic but rather indicate that there may be a problem with the kidneys and that further testing is required to
make a diagnosis and determine the cause. Results of the panel are usually considered together, rather than separately.
Individual test result can be abnormal due to causes other than kidney disease, but taken together with risks and signs and
symptoms, they may give an indication of whether kidney disease is present.

CRM No :9116159
Sample Recd. Time: 10-11-2024 10:26
Report Time: 10-11-2024 13:27 Authorized Signatory
Patient Name: KIRAN LASOD Dr. Murari lal Dhanetwal
Patient ID: 9116159 MBBS,MD (Pathology)
Scan For Report Scan To Verify
Consultant Pathologist.
Page 6 of 10
 Name: KIRAN LASOD Age/Gender: 55 Years/Female
0000009116159

Referred By: Client Name: Laxmi laboratory

Collection Date: 09-11-2024 14:29:00 Report Release Date: 10-11-2024 13:27:40

GD Marwar Health Package

No. Investigation Observed Value Unit Biological Reference Interval

1 Testosterone 23.97 ng/dL 0 – 76

Serum, Method: CLIA

Interpretation
Testosterone is the main sex hormone (androgen) in men. It is responsible for male physical characteristics. It is present in large
amounts in males during puberty and in adult males to regulate the sex drive and maintain muscle mass. In women, testosterone
is converted to estradiol, the main sex hormone in females. Testosterone levels are diurnal, peaking in the early morning hours
(about 4:00 to 8:00 am), with the lowest levels in the evening (about 4:00 to 8:00 pm). Levels also increase after exercise and
also decrease with age. Testosterone test may be used to help evaluate conditions such as delayed or precocious (early) puberty
in boys, decreased sex drive in men and women, erectile dysfunction in men, infertility in men and women, testicular tumors in
men, hypothalamus or pituitary disorders, hirsutism and virilization in girls and women.

2 Vitamin B12 159.0 pg/ml 120 - 807

Serum, Method: CLIA

Interpretation
Low B12 level in a person with signs and symptoms indicates that the person has a deficiency but does not necessarily reflect
the severity of the anemia or associated neuropathy. Vitamin B12 levels are decreased in megaloblastic anaemia, partial/total
gastrectomy, pernicious anaemia, peripheral neuropathy, chronic alcoholism, senile dementia, and treated epilepsy. Associated
increased in homocysteine levels and Vitamin B12 has better predictivity for cardiovascular disease and deep vein thrombosis.
Holo-Transcobalamin II levels and methylmalonic acid levels are more accurate markers of active Vitamin B12 component.
Additional tests are usually done to investigate the underlying cause of the deficiency.
In method comparison study done at our centre, we found acceptable correlation and these results showed that there was no
statistically significant between our methods and other Lab procedures (like, CLIA, CMIA, ELISA, IFA etc). The harmonization
between total vitamin B12 assays is variable and individual results can differ significantly between assays. Though cut-off
value of 200 pg/mL was used commonly, however, since there is not a reference method for measuring vitamin B12, this cut-
off value may not be suitable to use in the evaluation of cobalamin deficiency diagnosis. Until the harmonization study between
measurement methods is concluded, it is always suggested by NABL that laboratories should use their own reference values or
reference values for Lab assay methods instead of cut-off value of 200 pg/mL.

3 25 - OH Vitamin D 27.38 ng/mL Deficiency: <20

Serum, Method: CLIA Insufficiency: 20 - 30
Sufficiency: 30 - 100
Toxicity: > 100

Interpretation
1. The 25-hydroxyvitamin D is the major form found in the blood and is the relatively inactive precursor to the active hormone,
1,25-dihydroxyvitamin D. Because of its long half-life and higher concentration, 25-hydroxyvitamin D is commonly measured
to assess and monitor vitamin D status in individuals. A low blood level of 25-hydroxyvitamin D may mean that a person is not
getting enough exposure to sunlight or enough dietary vitamin D to meet his or her body's demand or that there is a problem
with its absorption from the intestines.

CRM No :9116159
Sample Recd. Time: 10-11-2024 10:26
Report Time: 10-11-2024 13:27 Authorized Signatory
Patient Name: KIRAN LASOD Dr. Murari lal Dhanetwal
Patient ID: 9116159 MBBS,MD (Pathology)
Scan For Report Scan To Verify
Consultant Pathologist.
Page 7 of 10
 Name: KIRAN LASOD Age/Gender: 55 Years/Female
0000009116159

Referred By: Client Name: Laxmi laboratory

Collection Date: 09-11-2024 14:29:00 Report Release Date: 10-11-2024 13:27:40

GD Marwar Health Package

Interpretation

2. Vitamin D is a fat soluble vitamin and exists in two main forms as cholecalciferol (vitamin D3) which is synthesized in skin
from 7-dehydrocholesterol in response to sunlight exposure & Ergocalciferol(vitamin D2) present mainly in dietary
sources.Both cholecalciferol & Ergocalciferol are converted to 25(OH)vitamin D in liver. 3. Testing for 25(OH) vitamin D is
recommended as it is the best indicator of vitamin D nutritional status.

CRM No :9116159
Sample Recd. Time: 10-11-2024 10:26
Report Time: 10-11-2024 13:27 Authorized Signatory
Patient Name: KIRAN LASOD Dr. Murari lal Dhanetwal
Patient ID: 9116159 MBBS,MD (Pathology)
Scan For Report Scan To Verify
Consultant Pathologist.
Page 8 of 10
 Name: KIRAN LASOD Age/Gender: 55 Years/Female
0000009116159

Referred By: Client Name: Laxmi laboratory

Collection Date: 09-11-2024 14:29:00 Report Release Date: 10-11-2024 13:27:40

GD Marwar Health Package

No. Investigation Observed Value Unit Biological Reference Interval

Iron Studies (Iron,TIBC, Transferrin saturation)

1 Iron 79.0 µg/dL 50 - 170

Serum, Method: Ferene

2 TIBC 389.0 µg/dL 250-450

Serum, Method: Calculated

3 Transferrin saturation 20.31 % 20 - 50

Serum, Method: Calculated

Interpretation
1. Serum iron measures the level of iron in the liquid portion of the blood. Low iron levels may seen in anemia (microcytic and
hypochromic) . High levels of serum iron in hereditary hemochromatosis, multiple blood transfusions, and a few other
conditions.
2. TIBC (Total iron-binding capacity) measures all the proteins in blood available to bind with iron, including transferrin.TIBC
test is a good indirect measurement of transferrin. The body produces transferrin in relationship to the need for iron. When iron
stores are low, transferrin levels increase and vice versa. Since transferrin is the primary iron-binding protein, the TIBC test is a
good indirect measurement of transferrin availability.

CRM No :9116159
Sample Recd. Time: 10-11-2024 10:26
Report Time: 10-11-2024 13:27 Authorized Signatory
Patient Name: KIRAN LASOD Dr. Murari lal Dhanetwal
Patient ID: 9116159 MBBS,MD (Pathology)
Scan For Report Scan To Verify
Consultant Pathologist.
Page 9 of 10
 Name: KIRAN LASOD Age/Gender: 55 Years/Female
0000009116159

Referred By: Client Name: Laxmi laboratory

Collection Date: 09-11-2024 14:29:00 Report Release Date: 10-11-2024 13:27:40

GD Marwar Health Package

No. Investigation Observed Value Unit Biological Reference Interval

HbA1c (Whole Blood)

1 HBA1c-Glycated Haemoglobin 6.3 % Non-diabetic: 4-6

EDTA Whole Blood, Method: HPLC Excellent Control: 6-7
Fair to good control: 7-8
Unsatisfactory control: 8-10
Poor Control: >10
2 Estimated Average Glucose (eAG) 134.11 mg/dL 90-120 mg/dL : Good control
EDTA Whole Blood, Method: Calculated 121-150 mg/dL : Fair control
151-180 mg/dL : Unsatisfactory
control
>180 mg/dL : Poor control

Interpretation
1.The term HbA1c refers to Glycated Haemoglobin. Measuring HbA1c gives an overall picture of what the average blood sugar
levels have been over a period of weeks/month. Higher the HbA1c, the greater the risk of developing diabetes-related
complications.
2.HbA1c has been endorsed by clinical groups and ADA (American Diabetes Assocation) guidelines 2012, for the diagnosis of
diabetes using a cut-off point of 6.5%. ADA defined biological reference range for HbA1c is between 4-6%. Patients with
HBA1c value between 6.0-6.5% are considered at risk for developing diabetes in the future. Trends in HbA1c area a better
indicator of glucose control than standalone test.
3.To estimate the eAG from the HbA1c value, the following equation is used: eAG(mg/dl) =28.7*A1c-46.7.
4.Diabetic must aspire to keep values under 7% to avoid the various complications resulting from diabetes.
5.Certain conditions can give rise to a spuriously low HbA1C values. Such conditions include Hemolytic anemias, certain
hemoglobinopathies (Hb SS, HbSC, Hb CC, unknown variant), recent blood transfusion,acute blood loss, hypertriglyceridemia,
drugs (eg dapsone, ribavirin, trimethoprim-sulfamethoxazole, hydroxyurea, vitamin C/E), chronic liver disease.
6.Certain conditions can give rise to a spuriously high HbA1C values. Such conditions include Iron deficiency, vitamin B12
deficiency, alcoholism, uremia, hyperbilirubinemia, drugs (chronic ingestion of salicylates in high doses and opiate addiction).
Note:The reportable range for HbA1C HPLC analyser is 3.8 % to 18.5 %, eAG calculation not possible above or below this
range. In such scenario, observed HbA1c results may not be truly representative of the glycemic control and need to be cross
checked by other methods of testing like fructosamine test.

End Of Report

CRM No :9116159
Sample Recd. Time: 10-11-2024 10:26
Report Time: 10-11-2024 13:27 Authorized Signatory
Patient Name: KIRAN LASOD Dr. Murari lal Dhanetwal
Patient ID: 9116159 MBBS,MD (Pathology)
Scan For Report Scan To Verify
Consultant Pathologist.
Page 10 of 10
 QUALITY POLICY
GENERAL DIAGNOSTICS INTERNATIONAL (P) Ltd. maintains the highest standards of quality control in all aspects
of laboratory work. The purpose of our laboratory’s Quality Management System is to ensure that:

Principles of all accreditations, including that of NABL - ISO1518:2012 (National Accreditation Board of Laboratories) are adhered
for each test in the scope of the accreditation, and beyond.
Test methods, processes and control mechanisms are timely updated and fully validated to ensure the accuracy and
reliability of our test results.

The objectives of our Quality Control system are:

Use Bar-Coded operations to enable full traceability throughout the sample flow process and to ensure sample handling
procedures and environmental conditions are managed well and there is no or minimal affect on the results.
Continually improve the practices of our clients, franchise partners, associate doctors, clinics and hospitals and monitor their
training needs. Be proactive in identifying gaps in the processes being followed. Guide them to ensure that the patients are
served in the best possible way.
Report the results with accuracy and clarity in a timely manner. Do a root cause analysis whenever there is a deviation against
protocols and find solutions to the identified causes.
Ensure a continual enhancement, implementation and maintenance of the quality system and seek improvement in the
effectiveness of the quality system from experts at regular intervals.
Meet and exceed expectations with respect to turn-around time, sample collection hygiene & reliability of service.
Ensure that each test is performed by qualified and trained staff. Provide opportunities to the staff so that they can increase
their knowledge and use the same for self and organizational betterment.
Ensure that the equipment used are best in class, properly maintained and calibrated and where possible, measurements are
traceable to recognized standards. Also explore methods which may lead to improvement in equipment performance and
methodologies used for conducting tests.
Enable technology upgrades to achieve higher accuracy and reduced complexities.
Use internal audits and other checks to ensure the quality system complies with requirements; ensure problems are
investigated promptly, root cause(s) established and effective action taken to prevent a recurrence.
Have a smooth communication mechanism to ensure information is made available as rapidly as possible to those who need
it, both internal and external to the organization.
Monitor, help and support our franchise and service partners to be sensitive on all aspects of service delivery and to ensure
quality standards are followed with no exceptions.

CONDITIONS of REPORTING
01. It is presumed that the specimen accompanying the TRF (Test Requisition Form where 07. For certain category of tests, the report may carry a “PRELIMINARY” status implying
the details of patient are recorded) is of the same patient whose details are there in the that the results are yet to be reported for one (or more) tests. For example, in the case
TRF. with certain microbiology tests, a “FINAL” culture, identification or drug susceptibility
02. A test requested might not be performed due to the following reasons(s): result might be pending. In such case, the status “RESULT PENDING” will be mentioned
2.1 Insufficient quantity of specimen required to conduct the test. on report. The same shall be replaced by the test results whenever it is ready.
2.2 Poor quality of the Specimen not meeting the quality criteria 08. If the collection date or any other details was not stated in the Test Requisition Form,
(hemolysis of sample/clotted.) the same will not be printed on the report. In cases where the missing information is
2.3 Incorrect specimen type as required to conduct a test. mandatory for report generation or meeting accreditation guidelines, the sample
03. Test(s) may be patly or fully cancelled due to incorrect test code, incorrect name of the shall not be processed at all.
test or incorrect type of specimen. A communication shall be made and it is expected 09. Tests parameters excluded from the “scope” of NABL accreditation shall be marked
that a fresh specimen will be sent to laboratory for analysis of same parameter(s). by asterisks.
04. The results of laboratory investigation are dependent on the quality of the specimen as 10. In case you are not the intended recipient of the report, please immediately inform
well as the assay procedures/technologies used. All samples collected for tests are the same to the issuing entity. Any use, disclosure, copy or distribution of any
required to be prepared, stored, labeled and brought to processing laboratory as per the contents of such report, is unlawful and is strictly prohibited.
prescribed guidelines of GENERAL DIAGNOSTICS. 11. Some test may be referred to other laboratories to provide a wider test menu to the
05. GENERAL DIAGNOSTICS laboratory cannot be held liable for incorrect results of a sample patients. The details of the laboratory where the sample was referred to, can be
which deviated from the guidelines issued. obtained from Customer Care department.
06. There can be several factors like sample’s unintended exposure to heat or travel through 12. Claims of comparing results against that from a different laboratory shall be looked
rough terrain which affect the quality of test results. Therefore a 2% chance of error/ into only if it was the same sample which was split and sent in same conditions to all
deviation in results is a possibility. laboratories and processed on the same technology.

इस का मूल आधार है “बेटी”

माता पता ही नह , देश का स ान है “बेटी” बेटी बचाओ बे पढ़ाओ
GENERAL DIAGNOSTICS INTERNATIONAL (P) LTD., Plot - 06, Sector-24, Turbhe, Navi Mumbai, Maharashtra, India - 400 705.
022 - 4045 0000 / +91 98717 15111 [email protected] www.gd-lab.com